Suppr超能文献

半枝莲和白花蛇舌草药对联合顺铂通过NRF2-FTH1自噬降解途径调节氧化应激协同抑制卵巢癌进展。

Scutellaria barbata D.Don and Hedyotis diffusa Willd herb pair combined with cisplatin synergistically inhibits ovarian cancer progression through modulating oxidative stress via NRF2-FTH1 autophagic degradation pathway.

作者信息

Sui Xue, Gao Bingqing, Zhang Liu, Wang Yanmin, Ma Junnan, Wu Xingchen, Zhou Chenyu, Liu Min, Zhang Lin

机构信息

Institute (College) of Integrative Medicine, Dalian Medical University, Dalian, 116044, China.

School of Pharmacy, Anhui Xinhua University, Hefei, 230088, China.

出版信息

J Ovarian Res. 2024 Dec 19;17(1):246. doi: 10.1186/s13048-024-01570-6.

Abstract

BACKGROUND

Cisplatin (DDP) is one of the most effective anticancer drugs, commonly used to treat advanced ovarian cancer (OC). However, DDP has significant limitations of platinum-based drugs, including chemical resistance and high-dose toxic side effects. Traditional Chinese medicines (TCMs) often presented in the form of formula, in which the herb pair was the basic unit. Scutellaria barbata D.Don and Hedyotis diffusa Willd (SB-HD) are famous TCMs herb pair that have been shown to help treat multiple types of cancers. However, the synergistic effects and mechanism of combination of SB-HD and DDP to enhance DDP chemosensitivity in OC are still unknown.

RESULTS

In vitro, we found that the optimal proportion of SB-HD to inhibit the proliferation of OC cells was 2:1, SB-HD and DDP were shown to synergistically reduce the viability of OC cells, inhibit the colony formation, promote cell cycle arrest and apoptosis, as well as inhibit cell migration and invasion. In vivo, combination treatment significantly inhibited the growth of subcutaneous tumors in BALB/c nude mice and reduced the toxic side effects of DDP. Mechanistically, SB-HD and DDP combination treatment significantly promoted oxidative stress response, decreased MMP, inhibited ATP production, decreased ROS levels and increased SOD activity, increased the expression of NRF2, HO-1, ATG5 and LC3, decreased the expression of p62 and FTH1 both in OC cells and tumor tissue of mice. Inhibitor 3-MA (Methyladenine, autophagy inhibitor) and Fer-1 (Ferrostatin-1, iron ion inhibitor) can effectively reverse the expression changes of the key target proteins, but not ZnPP (Zinc protoporphyrin, HO-1 inhibitor). Through bioinformatics analysis, it was found that the abnormal expression level of NRF2 and FTH1 mRNA has a high prognostic value, at the same time, the other four key proteins respectively or interacting with NRF2 and FTH1, also play important roles in the occurrence and development of OC.

CONCLUSION

Our findings uncover a synergistic effect of SB-HD and DDP against OC through modulating oxidative stress via NRF2-FTH1 autophagic degradation pathway, which may provide an important theoretical foundation for the use of SB-HD and a new strategy for enhancing DDP chemosensitivity as well as reducing toxic side effects.

摘要

背景

顺铂(DDP)是最有效的抗癌药物之一,常用于治疗晚期卵巢癌(OC)。然而,DDP具有铂类药物的显著局限性,包括化学耐药性和高剂量毒副作用。中药通常以方剂的形式呈现,其中药对是基本单位。半枝莲和白花蛇舌草是著名的中药药对,已被证明有助于治疗多种类型的癌症。然而,半枝莲和白花蛇舌草与DDP联合增强OC中DDP化疗敏感性的协同作用及机制仍不清楚。

结果

在体外,我们发现半枝莲和白花蛇舌草抑制OC细胞增殖的最佳比例为2:1,半枝莲和DDP协同降低OC细胞活力,抑制集落形成,促进细胞周期停滞和凋亡,以及抑制细胞迁移和侵袭。在体内,联合治疗显著抑制BALB/c裸鼠皮下肿瘤的生长并降低DDP的毒副作用。机制上,半枝莲和DDP联合治疗显著促进氧化应激反应,降低线粒体膜电位(MMP),抑制ATP生成,降低活性氧(ROS)水平并增加超氧化物歧化酶(SOD)活性,增加核因子E2相关因子2(NRF2)、血红素加氧酶-1(HO-1)、自噬相关蛋白5(ATG5)和微管相关蛋白1轻链3(LC3)的表达,降低小鼠OC细胞和肿瘤组织中p62和铁蛋白重链1(FTH1)的表达。抑制剂3-甲基腺嘌呤(3-MA,自噬抑制剂)和铁死亡抑制剂1(Fer-1,铁离子抑制剂)可有效逆转关键靶蛋白的表达变化,但锌原卟啉(ZnPP,HO-1抑制剂)不能。通过生物信息学分析发现,NRF2和FTH1 mRNA的异常表达水平具有较高的预后价值,同时,其他四个关键蛋白分别或与NRF2和FTH1相互作用,在OC的发生发展中也起重要作用。

结论

我们的研究结果揭示了半枝莲和DDP通过NRF2-FTH1自噬降解途径调节氧化应激对OC具有协同作用,这可能为半枝莲的应用提供重要的理论基础,并为增强DDP化疗敏感性及降低毒副作用提供新策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验